J. Mukherjee

First name

J.

Last name

Mukherjee

Morgan, C. L., Mukherjee, J., Jenkins-Jones, S., Holden, S. E., & Currie, C. J. (2014). Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12302

View

Bannister, C. A., Holden, S. E., Jenkins-Jones, S., Morgan, C. L., Halcox, J. P., Schernthaner, G., et al. (2014). Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab. http://doi.org/10.1111/dom.12354

View

Morgan, C. L., Mukherjee, J., Jenkins-Jones, S., Holden, S. E., & Currie, C. J. (2014). Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortality. Diabetes Obes Metab. http://doi.org/10.1111/dom.12306

View

Durham, T. A., Lich, H., Viera, A. J., Fine, J. P., Mukherjee, J., Weinberger, M., & Dusetzina, S. B. (2017). Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation. Am J Cardiol. http://doi.org/10.1016/j.amjcard.2017.07.091

View

Desai, U., . Y. Kirson, N., Kim, J., Khunti, K., King, S., Trieschman, E., et al. (2018). Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc17-0662

View